CF Acquisition Corp. VIII appointed Mark Kaplan and Robert Sharp as members of the board. Mr. Kaplan will serve as a class I director and Mr. Sharp will serve as a class II director.

Additionally, effective March 16, 2022, the board appointed Mr. Sharp as a member of the audit committee and the compensation committee of the Board. Mr. Sharp replaces Mr. Steven Bisgay as a member of the audit committee. Mr. Kaplan, is currently the global chief operating officer of Cantor Fitzgerald & Co.

a position held since February 2018. Mr. Kaplan has also served as a director of CF Acquisition Corp. IV since December 2021.

From 2007 – 2017, Mr. Kaplan was chief operating officer for Société Générale in the Americas Prior to that position, Mr. Kaplan spent six years as the General Counsel for Société Générale, and for its investment banking subsidiary, Cowen & Co. Before joining Société Générale, Mr. Kaplan was the U.S. General Counsel of CBIC. And prior to that position was a managing director and director of litigation at Oppenheimer & Co.

Inc. Mr. Sharp, is currently Co-CEO of Ramy Brook. Mr. Sharp is also the president and CEO of KDS Partners LLC. Mr. Sharp has over 25 years of experience in corporate acquisitions and strategically building equity value, combining financial and operational expertise.

Previously, Mr. Sharp was a founding partner and member of the Executive Committee of MidOcean Partners, from February 2003 to December 2013. Previously, from September 1999 to February 2003, Mr. Sharp was a managing director at DB Capital Partners. Mr. Sharp joined DB Capital Partners from Investcorp International.

Mr. Sharp has served on numerous corporate boards throughout his career, including as the previous Chairman of Thomas Scientific. Mr. Sharp also served as a director of CF Finance Acquisition Corp. from March 2019 until consummation of its business combination with GCM Grosvenor Inc. in November 2020 and as a director of CF Finance Acquisition Corp.

III from November 2020 until consummation of its business combination with AEye Inc. in August 2021. Mr. Sharp has also served as a director of CF Acquisition Corp. VII since December 2021.

Mr. Sharp is a member of the advisory board of Mount Sinai Hospital, and a member of the Steering Committee of Duke University's Financial Economics Center.